Avicanna Inc (FWB:0NN) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of non-convertible debenture units Closed: C$2M raised · C$1,000 a unit · Warrants at C$0.2 for 36 months · free to trade Mar 1, 2027 Use of proceeds: General working capital, G&A expenses, production and manufacturing expenditures, and research and clinical development | Oct 29, 2026 | US$1.43M |
| Private placement of units Closed: C$500,000 raised · C$0.15 a unit · ½ warrant at C$0.2 Buyers: Michael Porter Use of proceeds: General working capital, G&A expenses, production and manufacturing expenditures, and research and clinical development | Aug 19, 2026 | US$361,690 |
| Private placement of units Closed: C$1.55M raised · C$0.2 a unit · ½ warrant at C$0.25 Use of proceeds: General working capital, G&A expenses, production and manufacturing expenditures, and research and clinical development | Feb 10, 2026 | US$1.14M |